Factors associated with uptake of optimal dose of IPTP-SP among pregnant women attending antenatal clinics of Soroti district, Uganda
Authors:
Open Access
- 22 January 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Malaria in pregnancy is a major Public Health problem globally especially in low- and middle-income countries, because it contributes significantly to maternal, foetal, and perinatal morbidity and mortality. Uptake of up to three doses (optimal dose) of intermittent preventive treatment using sulfadoxine pyrimethamine (IPTp-SP) has been shown to prevent malaria in pregnancy and placental malaria. We aimed to determine the factors associated with the uptake of optimal dose of IPTp-SP among pregnant women attending antenatal care in Soroti District. A cross-sectional study was conducted at selected health facilities in Soroti District between March and June 2023. Three hundred and forty-three pregnant women at 36 weeks gestation or more were enrolled into the study. Sociodemographic, obstetric, knowledge on malaria and health care service delivery factors were collected from the women to determine the factors associated with uptake of optimal dose of IPTpSP. Uptake of optimal dose of IPTp-SP was 86.6%. Factors associated with uptake of optimal dose of IPTp-SP were: knowledge about dangers of malaria in pregnancy (aOR: 2.42, 95%CI: 1.19–4.91), knowledge about IPTp-SP benefits (aOR: 4.15, 95%CI: 2.10–8.23) and having enough clean cups at the ANC clinic to facilitate directly observed therapy (DOT) (aOR 5.43, 95% CI: 2.44–12.1). Uptake of optimal dose of IPTp-SP was high. Knowledge about dangers of malaria in pregnancy, IPTp-SP benefits and, always having enough clean cups at the ANC to implement DOT were associated with optimal IPTp-SP uptake. There is need to increase awareness among pregnant women and facilitate Directly Observed Therapy in antenatal clinics as these will improve IPTp-SP uptake.Keywords
This publication has 41 references indexed in Scilit:
- Is improvement in indicators of women’s empowerment associated with uptake of WHO recommended IPTp-SP levels in sub-Saharan Africa? A multilevel approachBMJ Open, 2021
- Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in GhanaBMJ Global Health, 2021
- Uptake challenges of intermittent preventive malaria therapy among pregnant women and their health care providers in the Upper West Region of Ghana: A mixed-methods studyParasite Epidemiology and Control, 2021
- The Effectiveness of the Revised Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) in the Prevention of Malaria among Pregnant Women in Northern GhanaJournal of Tropical Medicine, 2020
- Impact of Malaria in Pregnancy on Risk of Malaria in Young Children: Systematic Review and Meta-AnalysesThe Journal of Infectious Diseases, 2020
- Factors Associated with Uptake of Intermittent Preventive Treatment of Malaria in Pregnancy: A Cross-Sectional Study in Private Health Facilities in Tema Metropolis, GhanaJournal of Tropical Medicine, 2019
- Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract InfectionsClinical Infectious Diseases, 2017
- Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth WeightClinical Infectious Diseases, 2015
- Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in UgandaPublic Health, 2008
- Intermittent Preventive Therapy with Sulfadoxine‐Pyrimethamine during Pregnancy: Seeking Information on Optimal Dosing FrequencyThe Journal of Infectious Diseases, 2007